Tag Archives: CAR-T therapy

Europe’s RNA Immunotherapy Enters a New Phase: Trials Scale Up, Deals Consolidate, and Regulators Move

Europe’s RNA immunotherapy sector is gaining speed with new in vivo CAR-T and mRNA vaccine trials. Germany approved the region’s first in vivo CAR-T study, marking regulatory progress. The UK’s Cancer Vaccine Launch Pad advances personalised mRNA cancer vaccine trials … Read the full press release